As expected, with the increase of early breast cancer patients in study population, decreased prevalence of abnormal serum CEA, CA125 and CA15-3 was shown, leading to limited sensitivity in early diagnosis of breast cancer. This evidence concerns the gene CEACAM5 and breast cancer.